Conmed (CNMD) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.27% |
| Dec 31, 2025 | 19.39% |
| Sep 30, 2025 | 8.78% |
| Jun 30, 2025 | 67.28% |
| Mar 31, 2025 | 111.32% |
| Dec 31, 2024 | 2.53% |
| Sep 30, 2024 | 8.53% |
| Jun 30, 2024 | 19.07% |
| Mar 31, 2024 | 40.17% |
| Dec 31, 2023 | 20.91% |
| Sep 30, 2023 | 227.32% |
| Jun 30, 2023 | 5.28% |
| Mar 31, 2023 | -18.95% |
| Dec 31, 2022 | -24.61% |
| Sep 30, 2022 | 14.56% |
| Jun 30, 2022 | -0.09% |
| Mar 31, 2022 | -17.76% |
| Dec 31, 2021 | 26.69% |
| Sep 30, 2021 | -6.42% |
| Jun 30, 2021 | 19.01% |
| Mar 31, 2021 | 24.52% |
| Dec 31, 2020 | 14.42% |
| Sep 30, 2020 | 26.14% |
| Jun 30, 2020 | -22.82% |
| Mar 31, 2020 | -39.16% |
| Dec 31, 2019 | 9.06% |
| Sep 30, 2019 | 23.58% |
| Jun 30, 2019 | 38.03% |
| Mar 31, 2019 | -21.18% |
| Dec 31, 2018 | -2.31% |
| Sep 30, 2018 | -14.92% |
| Jun 30, 2018 | 4.69% |
| Mar 31, 2018 | 73.73% |
| Dec 31, 2017 | -9.52% |
| Sep 30, 2017 | -16.26% |
| Jun 30, 2017 | -8.56% |
| Mar 31, 2017 | 60.20% |
| Dec 31, 2016 | -15.22% |
| Sep 30, 2016 | -7.45% |
| Jun 30, 2016 | -2.78% |
| Mar 31, 2016 | -25.94% |
| Dec 31, 2015 | -14.60% |
| Sep 30, 2015 | 26.26% |